Compass Minerals International, Inc. — Fiscal Q1 2023 Form 10-Q Summary
Business context and reporting period
The filing covers the three months ended December 31, 2022, Compass Minerals’ fiscal first quarter. The company produces salt and magnesium chloride through its Salt segment, sulfate of potash specialty fertilizer through Plant Nutrition, and is developing a lithium brine resource at its Ogden, Utah facility. Results are highly seasonal, with winter weather affecting salt demand and drought, rainfall, and fertilizer-market conditions affecting Plant Nutrition.
Key financial metrics
| Metric | Q1 FY2023 | Q1 FY2022 | Change |
|---|---|---|---|
| Sales | $352.4 million | $331.5 million | Up 6% |
| Gross profit | $70.0 million | $59.9 million | Up 17% |
| Gross margin | 20% | 18% | Up 2 percentage points |
| Operating earnings | $27.9 million | $20.4 million | Up 37% |
| Net earnings from continuing operations | $(0.3) million | $7.9 million | Declined |
| Net earnings | $(0.3) million | $2.4 million | Declined |
| Diluted earnings per share | $(0.01) | $0.07 | Declined |
| Adjusted EBITDA from continuing operations | $61.8 million | $58.4 million | Up 6% |
| Cash flow from operations | $2.1 million | $(14.3) million | Improved |
| Capital expenditures | $19.9 million | $14.5 million | Increased |
Cash and cash equivalents were $146.1 million at December 31, 2022, compared with $46.1 million at September 30, 2022. Total debt principal was $839.8 million, including $250.0 million of 2024 senior notes, $500.0 million of 2027 senior notes, $16.9 million of term loans, and $72.9 million under the accounts receivable facility. Debt, net of issuance costs, was $832.1 million. The company reported a consolidated total net leverage ratio of approximately 3.8x and compliance with applicable debt covenants.
Material changes versus the prior comparable period
- Salt sales increased 12% to $308.1 million. Volumes rose 2% to 3.521 million tons, while the combined average selling price increased 10% to $87.51 per ton. Salt operating earnings increased 20% to $47.1 million.
- Plant Nutrition sales declined 24% to $41.6 million as volumes fell to 45,000 tons from 83,000 tons. The average selling price increased 40% to $924 per ton, and operating earnings increased to $11.0 million from $9.5 million.
- Higher sales prices improved gross profit and operating earnings, but inflation, energy costs, logistics costs, foreign-exchange losses, and higher income taxes reduced net earnings.
- Income tax expense increased to $11.9 million from a $1.2 million benefit. The current quarter included a $6.1 million valuation allowance for U.S. deferred tax assets, and the effective tax rate was 103%.
- The prior-year period included a $5.5 million loss from discontinued operations and an $8.4 million impairment charge related to the former South American chemicals business. No discontinued-operations loss was reported in the current quarter.
- The company completed a $240.7 million net private placement of common stock to Koch Minerals & Trading. Koch received approximately 17% ownership and appointed two directors. Proceeds were used primarily to support lithium development, with approximately $40.7 million used to reduce debt.
Guidance, outlook, risks and unusual items
- Fiscal 2023 Salt volumes are expected to range from 11.35 million to 12.2 million tons, with Salt EBITDA guidance of $215 million to $255 million. Higher energy costs and unplanned North American highway-deicing downtime could push results toward the lower end.
- Fiscal 2023 Plant Nutrition guidance is 205,000 to 270,000 tons of sales volume and $30 million to $60 million of EBITDA. Drought, subsequent flooding and rainfall in California, fertilizer-price uncertainty, and a temporary January increase in natural-gas costs are key factors.
- Fiscal 2023 capital expenditures are expected to total $165 million to $220 million, including $75 million to $120 million for phase one of the lithium project. Management expects lithium market entry by 2025, but total required investment remains uncertain.
- Inflation increased estimated logistics costs by approximately $6 million to $8 million and product costs by approximately $3 million to $5 million during the quarter; the company recovered only part of these increases through pricing.
- Canadian provincial tax authorities have issued reassessments totaling $170.2 million, including interest, through December 31, 2022. The company disputes the reassessments, has posted a $143.4 million performance bond, and has paid $36.7 million to the authorities. Management believes reserves are adequate but acknowledges the ultimate outcome could be material.
- The company settled the SEC investigation in September 2022 for a $12 million civil penalty, of which $10 million remained payable by September 30, 2023. An independent compliance consultant is required for approximately one year.
- Disclosure controls and procedures were ineffective at December 31, 2022 because of three material weaknesses involving privileged IT access, sales pricing and order-entry controls, and inventory existence controls. Remediation efforts are underway.
- Operations at Ogden depend on Great Salt Lake brine levels, permits and mineral concentrations. Continued drought or regulatory restrictions could affect SOP, salt, magnesium chloride and future lithium production.
- Management believes available cash, operating cash flow and revolving-credit availability will meet liquidity needs over the next 12 months, but refinancing and covenant compliance remain important given the 2024 debt maturity and seasonal cash requirements.
Important facts for investors to verify
- Whether Salt volumes, winter weather and production reliability support the $215 million to $255 million Salt EBITDA outlook.
- Whether Plant Nutrition demand and pricing recover sufficiently to achieve the revised fiscal 2023 volume and EBITDA ranges.
- The effect of additional U.S. deferred-tax valuation allowances on future earnings and cash taxes.
- Progress and total funding requirements for the Ogden lithium project, including permitting and the planned 2025 market entry.
- Resolution, required collateral and potential cash exposure related to the Canadian tax reassessments.
- Remediation and testing of the three material weaknesses in internal control over financial reporting.
- Ability to refinance or repay the $250 million of senior notes due July 2024 while maintaining debt-covenant compliance and dividends.